HH-018 sesutecan

N/A

Report date: 2025/06/11 10:35:25

Base Information

Drug NameHH-018 sesutecan
Drug Alias NameCD98-targeting sesutecan antibody drug conjugate (Huahui Health/ProfoundBio)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate
Mechanisms of ActionDNA topoisomerase I inhibitorsL-type amino acid transporter 1 modulators
TargetsDNA topoisomerase IL-type amino acid transporter 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHuahui Health Ltd
China Registration ClassN/A

Develop Information

Active CompaniesProfoundBio (Suzhou) Co LtdHuahui Health Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A